COVID-19 Serology in People Living With HIV in Hong Kong

• Conditions: HIV Infections; SARS-CoV-2 Infection; Vaccination; Infection

• Registration Number: NCT05028881
• Lead Sponsor: Chinese University of Hong Kong

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-8-28
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Enrolling by invitation
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

Inclusion Criteria:<br><br> - adults of age 18 or above, with<br><br> - known HIV status<br><br> - infection with SARS-CoV-2 or completion of vaccination against SARS-CoV-2<br><br>Exclusion Criteria:<br><br> - unable to communicate in written/spoken Chinese or English<br><br> - concurrent mental illnesses<br><br> - prisoners<br><br> - absence of consent

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
SARS-CoV-2 antibody early response to infection;SARS-CoV-2 antibody early response to vaccination

Secondary Outcome Measures

Name	Time	Method
SARS-CoV-2 sustained post-infection antibody response;SARS-CoV-2 sustained vaccination response